Artelo Biosciences Inc. (ARTL)
Market Open
15 Jun, 14:42
NASDAQ (CM) NASDAQ (CM) Primary $
1. 34
-0.02
-1.4706%
$
3.17M Market Cap
- P/E Ratio
- Div Yield
52,516 Volume
0 Eps
$ 1.36
Previous Close Analysts:
Want to track ARTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Artelo Biosciences Inc. (ARTL) Statistics
Valuation metrics
Market Cap 3.17M
Enterprise value -6.34M
Trailing P/E (ttm) -0.07
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.15
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.5
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 253.13K
Average volume (90 days) 3.43M
Price summary
52-Week low 1.19
52-Week high 85.8
Beta -
50-Day moving average 2.12
200-Day moving average 2.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:3
Last split Date 10 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.08%
Return on equity -16.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -18.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.9
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 1.79%
Book value per share (mrq) 9.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
